Endothelial Progenitor Cell Status in Metabolic Syndrome

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Metabolic Syndrome and Related Disorders

• Publication date

  2010-06-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1089/met.2010.0803.ediPMID 20367241
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Decreased number and impaired functionality of endothelial progenitor cells in subjects with metabolic syndrome: implications for increased cardiovascular risk.

  2010cited by this paper
• Endothelial-Regenerating Cells: An Expanding Universe

  2010cited by this paper
• An underlying principle for the study of circulating progenitor cells in diabetes and its complications

  2008cited by this paper
• Assessing identity, phenotype, and fate of endothelial progenitor cells.

  2008cited by this paper
• Endothelial progenitor cells: identity defined?

  2008cited by this paper
• Impaired endothelial progenitor cell function predicts age-dependent carotid intimal thickening

  2008cited by this paper
• Arterial compliance and endothelium‐dependent vasodilation are independently related to coronary risk in the elderly: the Prospective Investigation of the Vasculature in Uppsala Seniors (PIVUS) study

  2008cited by this paper
• Technical notes on endothelial progenitor cells: ways to escape from the knowledge plateau.

  2008cited by this paper
• Metabolic syndrome, insulin resistance, and brachial artery vasodilator function in Framingham Offspring participants without clinical evidence of cardiovascular disease.

  2008cited by this paper
• Endothelial progenitor cell levels in obese men with the metabolic syndrome and the effect of simvastatin monotherapy vs. simvastatin/ezetimibe combination therapy.

  2008influential reference
• Metabolic syndrome, endothelial dysfunction, and risk of cardiovascular events: the Northern Manhattan Study (NOMAS).

  2008cited by this paper
• Obesity, insulin resistance and the metabolic syndrome.

  2007cited by this paper
• Circulating endothelial progenitor cells predict coronary artery disease severity.

  2006cited by this paper
• Effect of rosiglitazone on endothelial function and inflammatory markers in patients with the metabolic syndrome.

  2006cited by this paper
• Clinical and therapeutical implications of EPC biology in atherosclerosis

  2006cited by this paper
• Circulating CD34+ cells, metabolic syndrome, and cardiovascular risk.

  2006cited by this paper
• Reduced Number of Circulating Endothelial Progenitor Cells Predicts Future Cardiovascular Events: Proof of Concept for the Clinical Importance of Endogenous Vascular Repair

  2005cited by this paper
• Circulating endothelial progenitor cells are reduced in peripheral vascular complications of type 2 diabetes mellitus.

  2005cited by this paper
• Obesity, Insulin Resistance, and the Metabolic Syndrome: Determinants of Endothelial Dysfunction in Whites and Blacks

  2005cited by this paper
• Circulating endothelial progenitor cells and cardiovascular outcomes.

  2005cited by this paper
• Circulating endothelial progenitor cells, vascular function, and cardiovascular risk.

  2003cited by this paper
• Number and Migratory Activity of Circulating Endothelial Progenitor Cells Inversely Correlate With Risk Factors for Coronary Artery Disease

  2001cited by this paper

• Zusammenhänge zwischen pulmonaler Obstruktion und metabolischem Syndrom bei selbstständig und zu Hause lebenden Senioren

  2014cites this paper
• Dysfunctional Endothelial Progenitor Cells in Metabolic Syndrome

  2011cites this paper
• Circulating levels of endothelial progenitor cell mobilizing factors in the metabolic syndrome.

  2010cites this paper